The epithelial-to-mesenchymal transition in cancer: pathogenetic features

The epithelial‑to‑mesenchymal transition (EMT) is a cellular biological process, that occurs in a wide range of cells and tissues and is triggered by complex regulatory networks involving transcriptional control with SNAIL, ZEB1, ZEB2, Twist, SLUG, E‑cadherin, vimentin, tumor microenvironment and ge...

Full description

Bibliographic Details
Main Authors: E. A. Pasechnikova, V. N. Bodnya, D. V. Kadomtsev, A. Yu. Georgieva, V. A. Porhanov, D. D. Shevchuk
Format: Article
Language:Russian
Published: Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1 2022-06-01
Series:Инновационная медицина Кубани
Subjects:
Online Access:https://www.innovmedkub.ru/jour/article/view/543
_version_ 1797276905653665792
author E. A. Pasechnikova
V. N. Bodnya
D. V. Kadomtsev
A. Yu. Georgieva
V. A. Porhanov
D. D. Shevchuk
author_facet E. A. Pasechnikova
V. N. Bodnya
D. V. Kadomtsev
A. Yu. Georgieva
V. A. Porhanov
D. D. Shevchuk
author_sort E. A. Pasechnikova
collection DOAJ
description The epithelial‑to‑mesenchymal transition (EMT) is a cellular biological process, that occurs in a wide range of cells and tissues and is triggered by complex regulatory networks involving transcriptional control with SNAIL, ZEB1, ZEB2, Twist, SLUG, E‑cadherin, vimentin, tumor microenvironment and genetic characteristics. EMT is represented by the multi‑stage development and transformation of cells of the epithelial phenotype into cells that acquire mesenchymal features of various severity. These quasi‑mesenchymal cells are characterized by stemness, tumor heterogeneity, increasing invasiveness, drug resistance and a tendency to distant metastasis, which leads to the proliferation of neoplastic cells, tumor dissemination and initiation of metastasis, which induces the therapy resistance and the oncological recurrence.This review is based on the latest scientific publications about the EMT phenomenon, indexed in PubMed. The aim of the study was to evaluate the biochemical and molecular pathogenetic mechanisms of EMT and the effect of EMT markers on the progression of neoplastic processes and the effectiveness of the treatment. Nowadays the proper EMT scheme that combines all the molecular transformations of sells with quasi‑mesenchymal phenotype doesn’t exist. But analyzing the features of this cellular program, we can find the proper therapy, that could be able to suppress the plasticity of cancer cells, prevent EMT induction by blocking contextual signals, and induce mesenchymal‑epithelial transition. All these aspects will lead to the reduction of the risk of tumor dissemination and the increase of the effectiveness of cancer treatment.
first_indexed 2024-03-07T15:36:02Z
format Article
id doaj.art-c37fe52ab7334f158aeb7ff5266aa4c2
institution Directory Open Access Journal
issn 2541-9897
language Russian
last_indexed 2024-03-07T15:36:02Z
publishDate 2022-06-01
publisher Scientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1
record_format Article
series Инновационная медицина Кубани
spelling doaj.art-c37fe52ab7334f158aeb7ff5266aa4c22024-03-05T11:12:31ZrusScientific Research Institute, Ochapovsky Regional Clinical Hospital no. 1Инновационная медицина Кубани2541-98972022-06-0102859210.35401/2541-9897-2022-25-2-85-92332The epithelial-to-mesenchymal transition in cancer: pathogenetic featuresE. A. Pasechnikova0V. N. Bodnya1D. V. Kadomtsev2A. Yu. Georgieva3V. A. Porhanov4D. D. Shevchuk5Kuban State Medical UniversityKuban State Medical University; Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1Clinical Oncology Dispensary no. 1Kuban State Medical UniversityKuban State Medical University; Scientific Research Institute – Ochapovsky Regional Clinical Hospital no. 1Kuban State Medical UniversityThe epithelial‑to‑mesenchymal transition (EMT) is a cellular biological process, that occurs in a wide range of cells and tissues and is triggered by complex regulatory networks involving transcriptional control with SNAIL, ZEB1, ZEB2, Twist, SLUG, E‑cadherin, vimentin, tumor microenvironment and genetic characteristics. EMT is represented by the multi‑stage development and transformation of cells of the epithelial phenotype into cells that acquire mesenchymal features of various severity. These quasi‑mesenchymal cells are characterized by stemness, tumor heterogeneity, increasing invasiveness, drug resistance and a tendency to distant metastasis, which leads to the proliferation of neoplastic cells, tumor dissemination and initiation of metastasis, which induces the therapy resistance and the oncological recurrence.This review is based on the latest scientific publications about the EMT phenomenon, indexed in PubMed. The aim of the study was to evaluate the biochemical and molecular pathogenetic mechanisms of EMT and the effect of EMT markers on the progression of neoplastic processes and the effectiveness of the treatment. Nowadays the proper EMT scheme that combines all the molecular transformations of sells with quasi‑mesenchymal phenotype doesn’t exist. But analyzing the features of this cellular program, we can find the proper therapy, that could be able to suppress the plasticity of cancer cells, prevent EMT induction by blocking contextual signals, and induce mesenchymal‑epithelial transition. All these aspects will lead to the reduction of the risk of tumor dissemination and the increase of the effectiveness of cancer treatment.https://www.innovmedkub.ru/jour/article/view/543epithelial‑to‑mesenchymal transitiontumor microenvironmentstemnesstumor heterogeneitycancer stem cell
spellingShingle E. A. Pasechnikova
V. N. Bodnya
D. V. Kadomtsev
A. Yu. Georgieva
V. A. Porhanov
D. D. Shevchuk
The epithelial-to-mesenchymal transition in cancer: pathogenetic features
Инновационная медицина Кубани
epithelial‑to‑mesenchymal transition
tumor microenvironment
stemness
tumor heterogeneity
cancer stem cell
title The epithelial-to-mesenchymal transition in cancer: pathogenetic features
title_full The epithelial-to-mesenchymal transition in cancer: pathogenetic features
title_fullStr The epithelial-to-mesenchymal transition in cancer: pathogenetic features
title_full_unstemmed The epithelial-to-mesenchymal transition in cancer: pathogenetic features
title_short The epithelial-to-mesenchymal transition in cancer: pathogenetic features
title_sort epithelial to mesenchymal transition in cancer pathogenetic features
topic epithelial‑to‑mesenchymal transition
tumor microenvironment
stemness
tumor heterogeneity
cancer stem cell
url https://www.innovmedkub.ru/jour/article/view/543
work_keys_str_mv AT eapasechnikova theepithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT vnbodnya theepithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT dvkadomtsev theepithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT ayugeorgieva theepithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT vaporhanov theepithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT ddshevchuk theepithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT eapasechnikova epithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT vnbodnya epithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT dvkadomtsev epithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT ayugeorgieva epithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT vaporhanov epithelialtomesenchymaltransitionincancerpathogeneticfeatures
AT ddshevchuk epithelialtomesenchymaltransitionincancerpathogeneticfeatures